IBO
IMPACT BIO (IBO)
NYSE
$0.54-$0.002 (-0.35%)
Price as of Jun 23, 2026 7:10 PM EDT
  • $57.4M
    Market Cap
  • -66.95%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
32,000
N/A
N/A
N/A
94,000
N/A
Cost of Revenue
424,000
N/A
N/A
N/A
N/A
N/A
Gross Profit
-392,000
N/A
0
-100.00%
94,000
N/A
Sales and Marketing Expense
24,000
-96.21%
633,000
+100.95%
315,000
N/A
Research and Development Expense
-340,000
+22.30%
-278,000
-75.76%
-1.1M
N/A
Depreciation and Amortization Expense
1.1M
+2.32%
1.1M
-0.09%
1.1M
N/A
Total Operating Expenses
424,000
-98.53%
28.8M
+613.83%
4.0M
N/A
Operating Profit
-4.3M
-85.11%
-28.8M
+613.83%
-4.0M
N/A
Interest Income
N/A
N/A
N/A
N/A
13,000
N/A
Interest Expense
-793,000
-25.54%
-1.1M
+139.86%
-444,000
N/A
Interest Income and Expense and Net
-793,000
-25.54%
-1.1M
+147.10%
-431,000
N/A
Total Nonoperating Income and Expense
13,000
0.00%
13,000
-75.00%
52,000
N/A
Income before Taxes
-14.4M
-41.59%
-24.7M
+461.31%
-4.4M
N/A
Income Taxes
-2.6M
-7,918.18%
33,000
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-11.8M
-52.09%
-24.7M
+460.65%
-4.4M
N/A
Net Income from Continuing Operations Applicable to Common
-14.4M
-41.59%
-24.7M
+470.50%
-4.3M
N/A
Basic EPS and Net Income
-0.38
-83.48%
-2.30
+3,185.71%
-0.07
N/A
Diluted EPS and Net Income
-0.38
-83.48%
-2.30
+3,185.71%
-0.07
N/A
Basic Weighted Average Shares
31.6M
+193.30%
10.8M
-82.15%
60.2M
N/A
Diluted Weighted Average Shares
31.6M
+193.30%
10.8M
-82.15%
60.2M
N/A
Balance Sheet
Cash and Cash Equivalents
3,000
-99.85%
2.0M
+199,800.00%
1,000
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3,000
-99.85%
2.0M
+199,800.00%
1,000
N/A
Total Current Assets
411,000
-83.21%
2.4M
+637.35%
332,000
N/A
Accumulated Depreciation
N/A
N/A
13,000
+116.67%
6,000
N/A
Property and Plant and Equipment and Net
N/A
N/A
17,000
-94.08%
287,000
N/A
Total Long-Term Assets
N/A
N/A
17,000
-94.08%
287,000
N/A
Total Assets
17.4M
-14.22%
20.3M
-54.54%
44.6M
N/A
Income Taxes Payable
688,000
-78.95%
3.3M
+1.02%
3.2M
N/A
Total Short-Term Debt
N/A
N/A
8.9M
-26.47%
12.1M
N/A
Total Current Liabilities
1.2M
-88.12%
9.8M
-25.51%
13.1M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
34.7M
N/A
Total Long-Term Liabilities
1.4M
-78.95%
6.5M
+1.02%
6.5M
N/A
Total Liabilities
1.9M
-85.83%
13.1M
-20.27%
16.4M
N/A
Retained Earnings
-49.5M
+31.43%
-37.7M
+190.63%
-13.0M
N/A
Total Stockholders Equity
12.6M
+196.06%
4.3M
-83.11%
25.2M
N/A
Total Shares Outstanding
104.6M
+809.44%
11.5M
+15.04%
10.0M
N/A
Cash Flow
Cash from Operating Activities
-1.9M
-51.77%
-3.9M
+37.46%
-2.9M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
3,000
+50.00%
2,000
+113.33%
-15,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-109,000
-101.84%
5.9M
+106.46%
2.9M
N/A
Financials Ratio
Gross Margin
-1,225.00%
N/A
N/A
N/A
N/A
N/A
Operating Margin
-13,381.25%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-62.81%
-17.48%
-76.11%
N/A
N/A
N/A
Return on Equity
-140.36%
-16.26%
-167.62%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.35
+41.37%
0.25
N/A
N/A
N/A
Cash Ratio
0.003
-98.73%
0.20
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow